ArticleFrontiers in public health2025
Global trends in childhood urinary tract infections, 1990-2021: results from the GBD study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Antibiotic Resistance Pattern ofInfection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urinary tract infections (UTIs) represent a prevalent urological disorder in childhood populations with substantial clinical implications. This study reports global trends from 1990 to 2021 in incident cases, incidence rates, mortality counts, mortality rates, disability-adjusted life years (DALYs), and DALY rates attributable to childhood UTIs. Methods: Utilizing Global Burden of Disease (GBD) 2021 data, we analyzed incidence, mortality, and DALY rates (per 100,000 population) with 95% uncertainty intervals (UI) for children aged 0-14 years. Data spanned 204 countries and territories, stratified by age, sex, and geographic location. Temporal trends were quantified using: Segmented regression to compute Annual Percentage Change and Average Annual Percentage Change. Log-linear regression models to derive Estimated Annual Percentage Change with 95% confidence intervals (CI). Associations between disease burden indicators and the Socio-demographic Index (SDI) were characterized using generalized additive models (GAMs) to capture potential nonlinear relationships. Results: From 1990 to 2021, global incident cases of childhood UTIs increased by 10.31% (95% UI: 4.33-13.82), whereas the global incidence rate decreased by 4.65% (95% UI: -9.82 to -1.60). Concurrently, downward trends were observed in deaths, DALYs, mortality rates, and DALY rates. Notably, childhood UTIs burden demonstrated significant associations with regional socioeconomic development and environmental conditions. In low-SDI regions, incident cases surged by 63.43% (95% UI: 47.21-76.20). This starkly contrasts with the declines observed in high-middle and high-SDI regions. These findings underscore the elevated UTIs incidence rates in tropical countries, necessitating targeted resource allocation for prevention and clinical management. Conclusion: From 1990 to 2021, the global incidence rate of childhood UTIs exhibited a downward trend. However, this trend reversed over the past decade, with a marked increase in incidence rates. Significant disparities in incidence rates were observed across population groups globally, stratified by sex, age, geographical location, and socioeconomic status. The incidence rate of UTIs is higher among children in socioeconomically disadvantaged and tropical regions. A representative example is the sustained increase in UTIs incidence among children in South Asia. Conversely, incidence rates were higher in girls, while mortality and DALYs were significantly elevated in boys. To optimize resource allocation and ensure essential treatment reaches those in need, governments and health organizations must tailor interventions based on regional and population-specific burdens. These findings underscore the necessity of developing effective, tailored prevention and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.